Marcia Olandoski

Marcia Olandoski

Auto-generated profile, based on publicly available information

Marcia Olandoski

Pontifícia Universidade Católica do Paraná, Brasil

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Revista de Saúde Pública
Verified
Journal Article
Open access
JNJose Rocha Faria Neto
Jose Rocha Faria Neto
VBVivian Freitas Rezende Bento
Vivian Freitas Rezende Bento
CBCristina Pellegrino Baena
Cristina Pellegrino Baena
MOMarcia Olandoski
Marcia Olandoski
LGLuis Gonzaga de Oliveira Gonçalves
Luis Gonzaga de Oliveira Gonçalves
KBKatia Vergetti Bloch
Katia Vergetti Bloch
OBJECTIVE To determine the distribution of total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides in Brazilian adolescents, as well as the prevalence of altered levels of such parameters. METHODS Data from the Study of Cardiovascular Risks in Adolescents (ERICA) were used. This is a country-wide, school-based cross-sectional study that evaluated 12 to 17-year old adolescents living in cities with over 100,000 inhabitants. The average and distribution of plasma levels of total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides were evaluated. Dyslipidemia was determined by levels of total cholesterol ≥ 170 mg/dl, LDL cholesterol ≥ 130 mg/dl, HDL cholesterol < 45 mg/dL, or triglycerides ≥ 130 mg/dl. The data were analyzed by gender, age, and regions in Brazil. RESULTS We evaluated 38,069 adolescents – 59.9% of females, and 54.2% between 15 and 17 years. The average values found were: total cholesterol = 148.1 mg/dl (95%CI 147.1-149.1), HDL cholesterol = 47.3 mg/dl (95%CI 46.7-47.9), LDL cholesterol = 85.3 mg/dl (95%CI 84.5-86.1), and triglycerides = 77.8 mg/dl (95%CI 76.5-79.2). The female adolescents had higher average levels of total cholesterol, LDL cholesterol, and HDL cholesterol, without differences in the levels of triglycerides. We did not observe any significant differences between the average values among 12 to 14 and 15- to 17-year old adolescents. The most prevalent lipid alterations were low HDL cholesterol (46.8% [95%CI 44.8-48.9]), hypercholesterolemia (20.1% [95%CI 19.0-21.3]), and hypertriglyceridemia (7.8% [95%CI 7.1-8.6]). High LDL cholesterol was found in 3.5% (95%CI 3.2-4.0) of the adolescents. Prevalence of low HDL cholesterol was higher in Brazil’s North and Northeast regions. CONCLUSIONS A significant proportion of Brazilian adolescents has alterations in their plasma lipids. The high prevalence of low HDL cholesterol and hypertriglyceridemia, especially in Brazil’s North and Northeast regions, must be analyzed in future studies, to support the creation of strategies for efficient interventions.

8 December 2016 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
PKPaulo Kotze
Paulo Kotze
MSMansur Paulo Saab
Mansur Paulo Saab
BSBárbara Saab
Bárbara Saab
LKLorete Maria da Silva Kotze
Lorete Maria da Silva Kotze
MOMarcia Olandoski
Marcia Olandoski
CCClaudio Saddy Rodrigues Coy
Claudio Saddy Rodrigues Coy

1 January 2016 in Epilepsy & Behavior
Verified
Journal Article
Closed access
LPLuciano De Paola
Luciano De Paola
VTVera Cristina Terra
Vera Cristina Terra
CSCarlos Eduardo Silvado
Carlos Eduardo Silvado
HTHelio Afonso Ghizoni Teive
Helio Afonso Ghizoni Teive
APAndre Palmini
Andre Palmini
WLW. Curt LaFrance
W. Curt LaFrance

10 June 2015 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
PDF file
TMThyago Proenca Moraes
Thyago Proenca Moraes
MAMaria Cláudia Cruz Andreoli
Maria Cláudia Cruz Andreoli
MCMaria Eugênia Canziani
Maria Eugênia Canziani
DSDirceu Reis da Silva
Dirceu Reis da Silva
JCJacqueline Costa Teixeira Caramori
Jacqueline Costa Teixeira Caramori
RPRoberto Pécoits-Filho
Roberto Pécoits-Filho
Insulin resistance is a common risk factor in chronic kidney disease patients contributing to the high cardiovascular burden, even in the absence of diabetes. Glucose-based peritoneal dialysis (PD) solutions are thought to intensify insulin resistance due to the continuous glucose absorption from the peritoneal cavity. The aim of our study was to analyse the effect of the substitution of glucose for icodextrin on insulin resistance in non-diabetic PD patients in a multicentric randomized clinical trial. This was a multicenter, open-label study with balanced randomization (1:1) and two parallel-groups. Inclusion criteria were non-diabetic adult patients on automated peritoneal dialysis (APD) for at least 3 months on therapy prior to randomization. Patients assigned to the intervention group were treated with 2L of icodextrin 7.5%, and the control group with glucose 2.5% during the long dwell and, at night in the cycler, with a prescription of standard glucose-based PD solution only in both groups. The primary end-point was the change in insulin resistance measured by homeostatic model assessment (HOMA) index at 90 days. Sixty patients were included in the intervention (n = 33) or the control (n = 27) groups. There was no difference between groups at baseline. After adjustment for pre-intervention HOMA index levels, the group treated with icodextrin had the lower post-intervention levels at 90 days in both intention to treat [1.49 (95% CI: 1.23–1.74) versus 1.89 (95% CI: 1.62-2.17)], (F = 4.643, P = 0.03, partial η2 = 0.078); and the treated analysis [1.47 (95% CI: 1.01–1.84) versus 2.18 (95% CI: 1.81–2.55)], (F = 7.488, P = 0.01, partial η2 = 0.195). The substitution of glucose for icodextrin for the long dwell improved insulin resistance measured by HOMA index in non-diabetic APD patients.

5 August 2015 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
ACAna Beatriz B.A. Da Costa
Ana Beatriz B.A. Da Costa
CPCaio Pellizzari
Caio Pellizzari
GCGisah A. Carvalho
Gisah A. Carvalho
BSBeatriz C. Sant'Anna
Beatriz C. Sant'Anna
RMRafaela L. Montenegro
Rafaela L. Montenegro
MCMauricio Carvalho
Mauricio Carvalho

28 March 2015 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
PKPaulo Kotze
Paulo Kotze
TYTakayuki Yamamoto
Takayuki Yamamoto
SDSilvio Danese
Silvio Danese
YSYasuo Suzuki
Yasuo Suzuki
FTFabio Vieira Teixeira
Fabio Vieira Teixeira
ASAntonino Spinelli
Antonino Spinelli
Both adalimumab [ADA] and infliximab [IFX] seem to be effective in the prevention of early postoperative endoscopic recurrence [EPER] after ileocaecal resection in Crohn’s disease [CD] patients. There is lack of data with direct comparison between the two agents in the postoperative scenario. The aim of this study was to compare the rates of EPER in patients treated with ADA and IFX after ileocaecal resection for CD. This was a multicentre retrospective analysis of EPER rates in CD patients after ileocaecal resections, from seven referral centres in three countries. Endoscopic recurrence was defined as Rutgeerts’ score ≥ i2. The patients were allocated according to treatment to two groups: ADA or IFX. The EPER rates were compared between the two treatment groups. Among the 168 patients included in the database, 96 received anti-tumour necrosis factor [TNF] agents after resection [37 in the ADA and 59 in the IFX groups] and were included in this comparative study. The groups were comparable in all baseline characteristics, mainly age, gender, previous resections, perianal CD, and mono or combination therapy. EPER was identified in 9/37 [24.32%] in the ADA group vs 16/59 [27.12%] in the IFX group [p = 0.815]. In this retrospective direct comparison between ADA and IFX therapy after ileocaecal resection, there was no significant difference between the two anti-TNF agents in terms of EPER rates. However, prospective randomised studies are needed to confirm these data and better define the role of each agent in the prevention of EPER.